Novo Nordisk CEO Mike Doustdar says Ozempic maker looking for deals
Nordisk is looking for deals more than ever, the Danish drugmaker's CEO said Wednesday in an interview with CNBC. “If…
Novo Nordisk A/S
Eli Lilly (LLY) earnings in the first quarter of 2026
Eli Lilly on Thursday reported first-quarter earnings and revenue that beat estimates and raised its full-year sales outlook by $2…
Eli Lilly Stock Rising Rapidly, Proving Stock Plunge Was a Mistake
Obesity drug giant Eli Lilly reported a monster first quarter on Thursday, strengthening our conviction to hold the stock after…
The growing LPG-1 market
When Branneisha Cooper began receiving the GLP-1 injection in Mounjaro in late 2022, she heard online that she could experience…
UnitedHealth Group (UNH) earnings in the first quarter of 2026
A UnitedHealthcare sign is displayed on its office building in Minnetonka, Minnesota, U.S., on Dec. 11, 2025. Tim Evans |…
Amazon launches GLP-1 weight loss program
Amazon GLP-1 Treatment Source: Amazon Inc. Amazon is delving into the burgeoning weight loss market, unveiling a new program Tuesday…
Novo Nordisk partners with OpenAI as hopes rise for AI drug discovery
Nordisk is partnering with OpenAI to “bring new and better treatment options to patients faster,” the Danish drugmaker said Tuesday.…
Trump prepares pharmaceutical tariffs of up to 100%
The Trump administration on Thursday imposed new tariffs on brand-name drugs from pharmaceutical companies that have not reached agreements with…
Novo says Wegovy pill outperforms Lilly's oral GLP-1
Wegovy semaglutide tablets. Michael Siluk | Universal Image Group | fake images The Wegovy pill showed more pronounced weight loss…
Eli Lilly GLP-1 Foundayo pill approved for obesity
The US Food and Drug Administration has approved Eli LillyThe GLP-1 pill, the company said, is a major milestone for…